Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jul 14;17(7):e87919.
doi: 10.7759/cureus.87919. eCollection 2025 Jul.

Recommendations for Addressing Suicidal Ideation Precipitated by Levetiracetam in the Treatment of Seizure Disorder: A Case Report and Review of the Literature

Affiliations
Case Reports

Recommendations for Addressing Suicidal Ideation Precipitated by Levetiracetam in the Treatment of Seizure Disorder: A Case Report and Review of the Literature

Ishrath Zamani et al. Cureus. .

Abstract

Suicidal ideation with levetiracetam is a relatively common occurrence in psychiatry and neurology practices. However, there are no established treatment guidelines, and more empirical evidence is needed to guide medical management in these cases. This report describes the case of a 17-year-old male patient with a history of poorly controlled epilepsy on oxcarbazepine who developed worsening anxiety after the initiation of levetiracetam and presented with suicidal ideation for the past three weeks; this was effectively managed with comprehensive care in our inpatient psychiatric center, resulting in the resolution of these thoughts. To support this case, we conducted a literature review using MEDLINE (Medical Literature Analysis and Retrieval System Online), PubMed, and Google Scholar to explore existing treatment protocols for patients experiencing suicidal ideation related to levetiracetam. This study proposes a treatment protocol, presented as a flowchart, that outlines various treatment modalities based on assessed risk factors in patients with suicidality associated with levetiracetam. We conclude that establishing a psychiatric treatment protocol will enable providers to effectively manage an amenable risk factor of suicidality. There is a need for further evidence-based research studies to strengthen our proposed treatment protocol.

Keywords: anti epileptics; levetiracetam; psychiatric disorders; recommendation; self-harm; suicidal ideation.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: Ann Manzardo declare(s) a grant and PWSA(USA) 2023 Medical & Scientific Conference from Health Resources and Services (HRSA) Grant, LivaNova. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Treatment protocol in patients with suicidality associated with levetiracetam.
SDQ: Strengths and Difficulties Questionnaire; SSI: Scale for Suicidal Ideation; CDI: Children’s Depression Inventory; QOLIE: Quality of Life in Epilepsy; CSSRS: Columbia Suicide Severity Rating Scale; ASQ: Ask Suicide-Screening Question; AED: antiepileptic drug; SSRI: selective serotonin reuptake inhibitors; CBT: cognitive behavioural therapy; PST: problem-solving therapy; SI: suicidal ideation; LEV: levetiracetam Mood stabilizing AEDs: valproate, lamotrigine, and oxcarbazepine

Similar articles

References

    1. Preventing Suicide: A Global Imperative. Geneva, Switzerland: World Health Organization; 2014. World Health Organization. Preventing suicide: A global imperative.
    1. Levetiracetam inhibits interleukin-1 beta inflammatory responses in the hippocampus and piriform cortex of epileptic rats. Kim JE, Choi HC, Song HK, et al. Neurosci Lett. 2010;471:94–99. - PubMed
    1. Psychiatric adverse events during levetiracetam therapy. Mula M, Trimble MR, Yuen A, Liu RS, Sander JW. Neurology. 2003;61:704–706. - PubMed
    1. Levetiracetam and suicidality: a case report and literature review. Esang M, Santos MG, Ahmed S. https://www.psychiatrist.com/pcc/levetiracetam-and-suicidality/ Prim Care Companion CNS Disord. 2020;22 - PubMed
    1. Levetiracetam: a comprehensive review. Crepeau AZ, Treiman DM. Expert Rev Neurother. 2010;10:159–171. - PubMed

Publication types

LinkOut - more resources